BUMC Thyroid Nodule and Cancer Research Group

Stephanie Lee, MD
Associate ProfessorStephanieLee


M.D. University of California, San Diego
Ph.D. Program in Physiology and Pharmacology, University of California, San Diego
Molecular  Endocrinology Post-doctoral fellowship, New England Medical Center, mentor: Richard Goodman Clinical Endocrinology Fellowship, New England Medical Center, mentor: Seymour Reichlin

General field of research:

Endocrinology, cancer, miRNA, ultrasonography

Affiliations other than medicine:

Evans Center for Interdisciplinary Biomedical Research
Section of Endocrinology, Department of Medicine
Division of GMS and Molecular Medicine
Section of Surgical Oncology
Department of Surgery
Section of Nuclear and Molecular Medicine
Department of Radiology
Section of Cytology
Department of Pathology

Contact information:

88 E. Newton Street
Phone: 617-638-8530

Evans 201
Phone: 617-638-8526
Fax: 617-638-7221


Research group information

Dr. Lewis Bravermanlebrave@bu.edu

Dr. Antonio De Las Morenas adlm@bu.edu

Dr. Rachel Factor refactor@bu.edu

Dr. Alan Farwell alan.farwell@bmc.org

Dr. Stephanie Lee stlee@bmc.org

Dr. David McAneny dmcaneny@bu.edu

Dr. Elizabeth Pearce epearce@bu.edu

Dr. Jennifer Rosen jennifer.rosen@bmc.org

Dr. Joshua Safer jsafer@bu.edu

Dr. Rathan Subramaniam rathan.subramaniam@bmc.org


thyroid cancer PET microRNA ultrasonography cytology

Summary of research interest:

The BUMC Thyroid Nodule and Cancer Research Group is a newly formed collaboration of experts to support a new area of research at BU in thyroid cancer and thyroid diagnostics. The multidisciplinary efforts in the area of thyroid ultrasonography, thyroid cytology, molecular diagnostics and diagnostic nuclear imaging by PET/CT will expand the scope of translational research at BU with direct clinical relevance to reduce unnecessary surgery and treatment of thyroid neoplasms.

Recent publications:

Cooper, DS, Doherty, GM, Haugen, BR, Kloos, RT, Lee, SL, Mandel, SJ, Mazzaferri, EL, McIver, B, Sherman, SI. Management Guidelines For Patients With Thyroid Nodules And Differentiated Thyroid Cancer, Thyroid (2006) 16:1-30 (published online: http://www.liebertonline.com/doi/pdf/10.1089/thy.2006.16.ft-1)

Noordzij J.P., Lee S..L, Bernet V.J., Payne R.J., Cohen S.M., McLeod I.K., Hier M.P., Black M..J, Kerr P.D., Richards M.L., Lo C.Y.,

Ananthakrishnan, S. and Lee, S.L.,”Follicular Thyroid Carcinoma,”  In: Rosen, B., Ed, In: Rosen, B., Ed, UpToDate, 2007

Raffaelli M., Bellantone R., Lombardi C.P., Cohen J.I., Dietrich M.S. Early prediction of hypocalcemia after thyroidectomy using parathyroid hormone: an analysis of pooled individual patient data from nine observational studies. J Am Coll Surg. (2007) 205:748-54.

Donahue, K.P., Shah, N.P., Lee, S.L., Oates, M.E., “Initial Staging of Differentiated Thyroid Carcinoma: The Continued Utility of Post-Therapy I-131 Whole-body Scintigraphy”, Radiology, 2008, 246:887-94.

Flanagan, J., Pineda, P., Knapp, P., De Las Morenas, A., Lee, S.L. and Braverman, L., “Expression of Cytokeratin 19 in the Diagnosis of Thyroid Papillary Carcinoma by Quantitative Polymerase Chain Reaction,” Endocrine Practice, 2008, 14:168-74.

Technologies available for sharing upon request:

Thyroid ultrasound, thyroid cytology, BRAF mutational analysis, miRNA profile, primary cell culture